These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Elastase in hyperpnea-induced guinea pig airway constriction. Lai YL; Lin YJ Eur J Pharmacol; 1998 Oct; 359(2-3):171-6. PubMed ID: 9832388 [TBL] [Abstract][Full Text] [Related]
7. Exaggerated pulmonary hypertension with monocrotaline in rats susceptible to chronic mountain sickness. Colice GL; Hill N; Lee YJ; Du H; Klinger J; Leiter JC; Ou LC J Appl Physiol (1985); 1997 Jul; 83(1):25-31. PubMed ID: 9216940 [TBL] [Abstract][Full Text] [Related]
8. L-arginine-related responses to pressure and vasoactive agents in monocrotaline-treated rat pulmonary arteries. Madden JA; Keller PA; Choy JS; Alvarez TA; Hacker AD J Appl Physiol (1985); 1995 Aug; 79(2):589-93. PubMed ID: 7592222 [TBL] [Abstract][Full Text] [Related]
9. Specific inhibition of p38 mitogen-activated protein kinase with FR167653 attenuates vascular proliferation in monocrotaline-induced pulmonary hypertension in rats. Lu J; Shimpo H; Shimamoto A; Chong AJ; Hampton CR; Spring DJ; Yada M; Takao M; Onoda K; Yada I; Pohlman TH; Verrier ED J Thorac Cardiovasc Surg; 2004 Dec; 128(6):850-9. PubMed ID: 15573069 [TBL] [Abstract][Full Text] [Related]
10. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats. Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms underlying the impairment of endothelium-dependent relaxation in the pulmonary artery of monocrotaline-induced pulmonary hypertensive rats. Nakazawa H; Hori M; Ozaki H; Karaki H Br J Pharmacol; 1999 Nov; 128(5):1098-104. PubMed ID: 10556948 [TBL] [Abstract][Full Text] [Related]
12. Role of nitric oxide and endothelin-1 in monocrotaline-induced pulmonary hypertension in rats. Mathew R; Zeballos GA; Tun H; Gewitz MH Cardiovasc Res; 1995 Nov; 30(5):739-46. PubMed ID: 8595621 [TBL] [Abstract][Full Text] [Related]
13. Role of inhibition of nitric oxide production in monocrotaline-induced pulmonary hypertension. Mathew R; Gloster ES; Sundararajan T; Thompson CI; Zeballos GA; Gewitz MH J Appl Physiol (1985); 1997 May; 82(5):1493-8. PubMed ID: 9134898 [TBL] [Abstract][Full Text] [Related]
14. Resveratrol inhibits right ventricular hypertrophy induced by monocrotaline in rats. Yang DL; Zhang HG; Xu YL; Gao YH; Yang XJ; Hao XQ; Li XH Clin Exp Pharmacol Physiol; 2010 Feb; 37(2):150-5. PubMed ID: 19566840 [TBL] [Abstract][Full Text] [Related]
15. [Effect of elastase inhibitor on pulmonary hypertension induced by monocrotaline]. Fu LJ; Zhou AQ; Shen J; Zhao W; Li F Zhonghua Er Ke Za Zhi; 2004 May; 42(5):375-8. PubMed ID: 15189699 [TBL] [Abstract][Full Text] [Related]
16. Reactive oxygen species and substance P in monocrotaline-induced pulmonary hypertension. Chen MJ; Chiang LY; Lai YL Toxicol Appl Pharmacol; 2001 Mar; 171(3):165-73. PubMed ID: 11243916 [TBL] [Abstract][Full Text] [Related]
17. [TRPC6 mediates the enhancements of pulmonary arterial tone and intracellular Ca2+ concentration of pulmonary arterial smooth muscle cells in pulmonary hypertension rats]. Zhang MF; Liu XR; Yang N; Lin MJ Sheng Li Xue Bao; 2010 Feb; 62(1):55-62. PubMed ID: 20179889 [TBL] [Abstract][Full Text] [Related]
18. [Effects of various doses of monocrotaline administration on the development of pulmonary hypertension and its regression in rats]. Kakusaka I; Kaneko N; Kiyatake K; Fujita A; Suzuki A; Nakano K; Okada O; Sugita T; Watanabe S; Kuriyama T Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Jan; 27(1):51-6. PubMed ID: 2501548 [TBL] [Abstract][Full Text] [Related]